Investing-News.Com
Information for Investors

CEL SCI CP, (CVM) Stock Ratings - Investing-News.Com
 

 Home   Market News   Analysis   Commentary   Education   Tools   Weekly Report 

Internet Search   Stock Search
   

 

CEL SCI CP, (CVM) Stock Rating Learn More

Our Overall Rating on CEL-SCI Corporation,  CVM is SELL
StockPickReport.Com research suggests CVM's price will move lower than the "open price" the day this rating was initiated.

This analysis is based on short-term stochastic and "relative strength" indicators.

With StockPickReport.Com's "Sell" rating, stochastic and "relative strength" numbers may agree, but not in all cases.

Investors, traders, and other market participants may find this a good opportunity to sell CVM, "sell calls", or "buy puts".

This may also be an opportunity to lower targets and raise stop/losses to protect capital.

Trading volume seems to be falling and CVM's closing price moved down during the week before this rating was initiated.

Our SELL Rating on CVM was issued on 03/25/08

CEL SCI CP Technical Rating



Ratings Provided by Stock-Letter-Daily.Com

Rate Any Stock
(enter symbol and click)

Stock Rating Definitions

Stock Ratings Home

Sponsored Links:

Software Forces CEL SCI CP Investors To Buy Low and Sell High The Position Cost Averaging Stock Investing Systems helps LONG-TERM investors in CEL SCI CP buy low and sell high every time guaranteed. Click Here To Learn More

We Give Precision Entry & Exit Points on CEL SCI CP. This software is specially designed to give precision entry and exit points on CEL SCI CP, or any other stock you choose.
Click Here to learn how to take control of your trading.

How To Know When CEL SCI CP Beats The Street. New Software Offers "One-Click" Stock Picks. The StockPickerRT will pick stocks for you every trading day based on earnings, volume & momentum. Maybe even CEL SCI CP, if they make the cut.
Click Here & Learn To
Pick Winners In An Uncertain Market



Related Searches: day trading tax  firstalert by neovest 

Research Home


Article Search


Advanced Search

StreetInsider Alerts

Latest Headlines

Updated Pictures of CEL-SCI Manufacturing Facility Available Online (PR Newswire)

New Data Points to Long Lasting Beneficial Effects of CEL-SCI's Rheumatoid Arthritis Vaccine (PR Newswire)

CEL-SCI Announces Expansion of Exclusive Licensing Agreement for Cancer Drug Multikine (PR Newswire)

CEL-SCI Takes Delivery of New Manufacturing Facility (PR Newswire)

CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect (PR Newswire)

CEL-SCI Expects to Take Delivery of New Manufacturing Facility on October 8, 2008 (PR Newswire)

CEL SCI CORP Financials (EDGAR Online Financials)

Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis (PR Newswire)

CEL SCI CORP Files SEC form 8-K, Other Events (EDGAR Online)

CEL SCI CORP Files SEC form 10-Q, Quarterly Report (EDGAR Online)

  Place Our Content On Your Site!  rss Powered By The Investing System Network
© 2006 Investing-News.Com, All Rights Reserved.